Ganesh Benzoplast
GANESHBE · Chemicals > Chemicals · Chairman: Rishi Ramesh Pilani · MD: Rishi Ramesh Pilani · Listing date: Dec. 28, 1994

Stock Price vs Company Growth
1d
3.5%
1w
9.9%
1m
11.0%
3m
23.8%
6m
37.7%
1y
44.0%
all
3.2%
Created with Highcharts 8.2.2SalesProfitPriceDividendQtr SalesOperating CashflowDec10Jun14Dec17Jun21Latest

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

105 3.5%
104
151
Company Overview

Sales
421 Cr
Growth: -2.8%
Profit after Tax
65.6 Cr
Growth: 3.7%
Small Cap
758 Cr
P/E: 11.5x
Industry P/E: 26.9x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals

Sales (Cr) ₹ 421
Growth -2.8%
EBITDA 23.2%
P/S 1.8x
Dividend 0.0%
P/E 11.5x
Book Value ₹ 76.8
PEG Ratio -4.1x
ROE 12.4%
P/B 1.4x
Shareholding Pattern

Institutions
Created with Highcharts 8.2.2Dec19Mar20Jun20Sep20Dec20Mar21Jun22Sep22Dec22Mar23
Promoters
Susram Financial Services & Realty Pvt.Ltd
16.93 %
Ganesh Risk Management Pvt.Ltd
7.97 %
Sushila Ramesh Pilani
5.59 %
Tarang Advisory Pvt. Ltd.
4.81 %
Rishi Ramesh Pilani
2.55 %
Created with Highcharts 8.2.2Dec19Mar20Jun20Sep20Dec20Mar21Jun22Sep22Dec22Mar23
Others
Stolt-Nielsen Singapore Pte Ltd.
9.8 %
Anil Vishanji Dedhia
4.7 %
Nishant Kailash Agarwal
2.56 %
Dalapatraj P Jain
1.32 %
Nidhi Jawahar
1.02 %
Created with Highcharts 8.2.2Dec19Mar20Jun20Sep20Dec20Mar21Jun22Sep22Dec22Mar23
Increase    Decrease    No change
Company Profile Detailed

:The company is engaged in the manufacturing and exporting of drug intermediates, pharmaceutical intermediates, bulk drug intermediates, food preservatives, lubricants, API/bulk drug, etc.
Investors (25)
Followers (1)